Novartis keeps CEO pay steady, but incoming chairman pay drops
BASEL (Reuters) - Novartis kept pay for its Chief Executive Joe Jimenez steady, after cutting it last year before a Swiss vote to force companies to accept shareholder limits on executive rewards.
Related Articles
- A Changed and Changing Executive Compensation Environment also mentions Executive Compensation
- Exclusive: Proxy firm Egan-Jones Withdraws Recommendation on Tempur Sealy also written by Reuters
- AIG Chairman Steve Miller to Step Down in July also written by Reuters
- Executive Compensation: What Will 2012 Bring? — The Harvard Law School Forum on Corporate Governance and Financial Regulation also categorized in BoardNews
- Cracker Barrel Holders Reject Biglari's Bid for Seat also categorized in BoardNews
- Tensions with the Board Not the Norm, Say 98 Percent of CEOs also categorized in BoardNews
- Coca-Cola Faces Renewed Pressure Over Executive Pay also written by Reuters
- Firms with female directors do better, study says also published in Chicago Tribune
- NACD BoardVision - NACD BoardVision – “The role of the board as company spokesperson” - Resources - NACD also categorized in BoardNews
- Still few women on boards also categorized in BoardNews
Login to comment.